A latest study published in JAMA Internal Medicine in the U.S. reveals some important findings. The report shows that cancer cases are rising among young people, i.e., those under the age of 50. However, the reason behind this is surprising. The study explains that the increase in cases is largely due to advanced diagnostic methods and growing awareness about cancer. This is a positive sign, because if cancer is detected early, it can be treated effectively.
The report also highlights that although the number of cases has increased, there is no need to panic as mortality rates have not gone up. In fact, in some cases, death rates have actually declined.
In short, improved diagnostic methods have led to an increase in case numbers. These methods allow for more precise and deeper detection, which is good news. Another encouraging point is that mortality rates have not increased.
Here are the key points from the study:
1. Screening is the main reason for rising cases: The study suggests that the rise in cancer among people under 50 is mainly due to better and more frequent screening and intensive diagnostic practices.
2. Stable mortality rates: For most cancers (such as thyroid, kidney, rectal, and pancreatic), despite more cases, the mortality rate among young adults has remained unchanged or even declined.
3.High-risk cancers: Out of the eight cancers studied, only two – colorectal (intestinal) and endometrial – showed a slight increase in mortality.
4. Breast and colorectal cancers: Cases of these cancers have increased among young adults, but thanks to early detection and treatments like immunotherapy, the death rate has almost halved.
5. Earlier screening: To enable earlier diagnosis, the U.S. has lowered the age for breast cancer screening from 50 to 40 and for colon cancer screening from 50 to 45.
Doctors in the U.S. caution that as more powerful diagnostic tools become available, cancers that may never actually harm a person’s health are also being detected. Treating such cancers that are not “clinically significant” creates unnecessary financial burdens and mental stress for young patients. Experts recommend that instead of rushing into treatment for every detected cancer, doctors should assess whether it is truly dangerous. If a tumor is small, continuous monitoring with patient consent may be the better strategy.
About The Author
